AU3537099A - Novel immortalized hepatic cell line originating in humans - Google Patents
Novel immortalized hepatic cell line originating in humansInfo
- Publication number
- AU3537099A AU3537099A AU35370/99A AU3537099A AU3537099A AU 3537099 A AU3537099 A AU 3537099A AU 35370/99 A AU35370/99 A AU 35370/99A AU 3537099 A AU3537099 A AU 3537099A AU 3537099 A AU3537099 A AU 3537099A
- Authority
- AU
- Australia
- Prior art keywords
- xenobiotics
- metabolism
- inhibits
- liver
- promotes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/067—Hepatocytes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/26—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase
- C12Q1/32—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving oxidoreductase involving dehydrogenase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2503/00—Use of cells in diagnostics
- C12N2503/02—Drug screening
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/04—Immortalised cells
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The present invention relates to a new immortalized hepatocyte culture of human (preferably human fetal) normal cell origin, a method of producing said culture, a screening method for a compound or a salt thereof which inhibits or promotes an enzyme activity involved in the metabolism of xenobiotics in the liver, or which inhibits or promotes the expression of a gene encoding an enzyme involved in the metabolism of xenobiotics in the liver, or which inhibits or promotes the induction of expression of a gene encoding an enzyme involved in the metabolism of xenobiotics in the liver, characterized by the use of said culture, a compound which inhibits or promotes an enzyme activity involved in the metabolism of xenobiotics in the liver, a compound which inhibits or promotes the expression of a gene encoding an enzyme involved in the metabolism of xenobiotics in the liver, or a compound which inhibits or promotes the induction of expression of a gene encoding an enzyme involved in the metabolism of xenobiotics in the liver, obtained using said screening method, or salts thereof. The immortalized hepatocyte culture of human normal cell origin of the present invention is useful in, for example, screening for compounds or salts thereof having therapeutic/preventive effects on hepatic insufficiency .
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10/119394 | 1998-04-28 | ||
JP11939498 | 1998-04-28 | ||
PCT/JP1999/002224 WO1999055853A1 (en) | 1998-04-28 | 1999-04-27 | Novel immortalized hepatic cell line originating in humans |
Publications (1)
Publication Number | Publication Date |
---|---|
AU3537099A true AU3537099A (en) | 1999-11-16 |
Family
ID=14760421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU35370/99A Abandoned AU3537099A (en) | 1998-04-28 | 1999-04-27 | Novel immortalized hepatic cell line originating in humans |
Country Status (7)
Country | Link |
---|---|
US (1) | US7186553B1 (en) |
EP (1) | EP1083223B1 (en) |
AT (1) | ATE341620T1 (en) |
AU (1) | AU3537099A (en) |
CA (1) | CA2329857A1 (en) |
DE (1) | DE69933445T2 (en) |
WO (1) | WO1999055853A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7473555B2 (en) * | 2000-04-27 | 2009-01-06 | Geron Corporation | Protocols for making hepatocytes from embryonic stem cells |
FR2828212B1 (en) * | 2001-08-03 | 2003-10-31 | Aventis Pharma Sa | METHODS OF DIAGNOSING AND PROGNOSING PARKINSON'S DISEASE |
EP1704227B1 (en) | 2003-10-10 | 2010-01-27 | Multicell Technologies, Inc. | Immortalized hepatocytes |
US10004826B2 (en) | 2010-10-06 | 2018-06-26 | Massachusetts Institute Of Technology | Implantable human liver tissue constructs and uses thereof |
WO2017062757A1 (en) | 2015-10-08 | 2017-04-13 | Massachusetts Institute Of Technology | In situ expansion of engineered devices for regeneration |
WO2021150300A1 (en) | 2020-01-22 | 2021-07-29 | Massachusetts Institute Of Technology | Inducible tissue constructs and uses thereof |
WO2022015902A1 (en) | 2020-07-14 | 2022-01-20 | Massachusetts Institute Of Technology | Synthetic heparin mimetics and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5506131A (en) * | 1987-06-05 | 1996-04-09 | The United States Of America As Represented By The Department Of Health And Human Services | Immortalized human cell lines containing exogenous cytochrome P450 genes |
US5665589A (en) * | 1988-12-14 | 1997-09-09 | The United States Of America As Represented By The Department Of Health And Human Services | Human liver epithelial cell lines |
US5869243A (en) * | 1996-03-05 | 1999-02-09 | Rhode Island Hospital | Immortalized hepatocytes |
WO1998008935A1 (en) | 1996-08-30 | 1998-03-05 | The University Of North Carolina At Chapel Hill | Immortalized human hepatic cell line |
WO2000065031A1 (en) | 1999-04-27 | 2000-11-02 | Takeda Chemical Industries, Ltd. | Human cell line showing stable expression of cytochromes p450 |
-
1999
- 1999-04-27 US US09/673,958 patent/US7186553B1/en not_active Expired - Fee Related
- 1999-04-27 AU AU35370/99A patent/AU3537099A/en not_active Abandoned
- 1999-04-27 CA CA002329857A patent/CA2329857A1/en not_active Abandoned
- 1999-04-27 AT AT99917169T patent/ATE341620T1/en not_active IP Right Cessation
- 1999-04-27 EP EP99917169A patent/EP1083223B1/en not_active Expired - Lifetime
- 1999-04-27 WO PCT/JP1999/002224 patent/WO1999055853A1/en active IP Right Grant
- 1999-04-27 DE DE69933445T patent/DE69933445T2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1083223A4 (en) | 2004-12-15 |
WO1999055853A1 (en) | 1999-11-04 |
CA2329857A1 (en) | 1999-11-04 |
US7186553B1 (en) | 2007-03-06 |
EP1083223A1 (en) | 2001-03-14 |
DE69933445D1 (en) | 2006-11-16 |
ATE341620T1 (en) | 2006-10-15 |
DE69933445T2 (en) | 2007-02-22 |
EP1083223B1 (en) | 2006-10-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baeuerle et al. | Chlorate—a potent inhibitor of protein sulfation in intact cells | |
CR20110483A (en) | PREGABALINE PREPARATION AND RELATED COMPOUNDS (RECORD DIVISIONAL 8765) | |
ATE238800T1 (en) | USE OF SQUALAMINE FOR PREPARING A DRUG FOR INHIBITING NHE | |
SG154438A1 (en) | Cleaning compound and method and system for using the cleaning compound | |
TW200726824A (en) | Cleaning compound and method and system for using the cleaning compound | |
MY121854A (en) | Method for producing 3-alkanoylindoles and 3-alkylindoles. | |
AU3537099A (en) | Novel immortalized hepatic cell line originating in humans | |
PT81308A (en) | Process for preparing a combination of dihydropyridines with ace(angiotensin converting enzymes) inhibitors useful as medicament | |
AUPN977296A0 (en) | Pharmaceutical agents | |
NZ322929A (en) | Process for the preparation of substituted aryl lactic acid containing cyclodesipeptides with 24 ring atoms | |
AU2612299A (en) | A fluorescence polarization screening method | |
GB2393735B (en) | Cell culture method for obtaining prostate-like acini | |
ES8707731A1 (en) | Oxindole antiinflammatory agents. | |
GR3030113T3 (en) | Ultrasensitive process for assaying cardiac troponine i | |
Raghunath et al. | Truncated profibrillin of a Marfan patient is of apparent similar size as fibrillin: intracellular retention leads to over-N-glycosylation | |
Sauer | Tetrahydromethanopterin methyltransferase, a component of the methane synthesizing complex of Methanobacterium thermoautotrophicum | |
WO2001025246A3 (en) | Chromogenic substrates of sialidase of bacterial, viral, protozoa, and vertebrate origin and methods of making and using the same | |
PL380526A1 (en) | Crystalline form of risedronate monosodium | |
MX207081B (en) | ||
Saffar et al. | Changes in mast cell number during the activation phase of an induced synchronized remodeling sequence in the rat | |
AU2182801A (en) | Method for producing adherent animal cells | |
WO2003019146A3 (en) | High throughput screening assays using fatty acid synthetic enzymes | |
Potter et al. | Simultaneous increases in cholesterol and dolichol synthesis after mitogen stimulation of mouse lymphocytes | |
TR200003517T2 (en) | The process of preparing the crystalline salts of amoxycillin | |
IL143229A0 (en) | Method for producing optically active 1-amino-4-(hydroxymethyl)-cyclopent-2-ene derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |